CRISPR Gene Editing Advances in Heart Failure, Cystic Fibrosis, and Cholesterol Treatment
Three new CRISPR-based therapies show promise for treating heart failure through mitochondrial enhancement, cystic fibrosis via lipid nanoparticle gene insertion, and elevated cholesterol with single-dose gene editing targeting ANGPTL3.